Low Anterior Resection Syndrome and Rectal Irrigation Study
LARRIS
1 other identifier
interventional
22
1 country
1
Brief Summary
Prospective study assessing treatment acceptability and the impact of rectal irrigation on patients with low anterior resection syndrome (LARS) in terms of quality of life and bowel function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2015
CompletedStudy Start
First participant enrolled
April 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedFirst Posted
Study publicly available on registry
January 29, 2020
CompletedJanuary 29, 2020
February 1, 2015
1 year
February 10, 2015
January 28, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
SF12
quality of life
pre intervention and 6 months post
Secondary Outcomes (4)
EORTC
pre intervention and 6 months post
Low anterior resection score
pre intervention and 6 months post
St Marks Faecal incontinence score
pre intervention and 6 months post
treatment acceptability questionnaire
post training for treatment and 6 months post treatment
Other Outcomes (1)
qualitative interviews
after 6 months treatment or drop out from treatment group
Study Arms (1)
Treatment
OTHERPeristeen given
Interventions
Eligibility Criteria
You may qualify if:
- patients who have undergone anterior resection for rectal neoplasia, patients who have had restored bowel continuity
- LARS score of \>20 (defined LARS syndrome)
- patients \> 18 years of age.
You may not qualify if:
- previous use of rectal irrigation
- patients who are unable to give informed consent
- patients who are not physically capable of performing the treatment in their home
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cardiff and Vale University Health Boardlead
- South East Wales Trials Unit (SEWTU)collaborator
- Tenovuscollaborator
Study Sites (1)
University Hospital of Wales
Cardiff, CF14 4XW, United Kingdom
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2015
First Posted
January 29, 2020
Study Start
April 1, 2015
Primary Completion
April 1, 2016
Study Completion
July 1, 2016
Last Updated
January 29, 2020
Record last verified: 2015-02